ArticleMolecular imaging and biology2013

Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.

Kristine E Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.